Aqvida

Germany 72 employees Updated 9 July 2026

Aqvida is a finished-dose manufacturer based in Germany. It appears in 68 regulatory filings across 10 regulators, without an active US DMF or CEP on file. Its filings concentrate with EMA, EDE (AE) and DPM (TN). Its GMP standing is certified by ZLG (DE) and EMA. Its most recent recorded inspection, by US FDA, closed on 8 December 2022 as VAI.

active US DMFs

valid CEPs

registered plants 1 with an FDA FEI number

filings across 10 regulators

These figures were checked against the regulators' own files on 25 July 2026

Plants

1 of 1 confirmed

Inspections

1 of 1 confirmed

EU GMP

1 of 1 confirmed

Sources: FDA Establishment Registration, read 4 May 2026. FDA drug inspection classifications, read 4 May 2026. EudraGMDP (MIA + third-country GMP certs), read 4 May 2026.

Inspection history

8 December 2022 VAI US FDA

NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.

Registered plants

Site	FDA FEI
Hamburg, United Arab Emirates	Not on file
Dassow, United Arab Emirates	Not on file
DASSOW, Germany	Not on file
Hamburg, Germany	Not on file
Germany, Germany	3017440477

Filings and GMP by regulator

Regulator	Filings	GMP certificates
EMA	16	2
EDE (AE)	12	None
DPM (TN)	9	None
ARCSA (EC)	9	None
SFDA (Saudi Arabia)	6	None
EFDA (ET)	5	None
ZLG (DE)	None	10

Comparing suppliers?

Choose your molecules and target markets. Aqvida comes back tiered against every other supplier able to file there.

Start for free

No sales call.

Open risk flags

The most recent inspection outcome was VAI, on 8 December 2022.

Sources on this page

FDA: Drug master files, establishment registration, inspection classifications
EDQM: Certificates of suitability
EudraGMDP and national regulators: GMP certificates